General Instructions
Follow these general instructions when preparing and sending your test results.
Precautions
All units of human blood or blood products used in preparing specimens, except those used in the Hepatitis and HIV Markers program, have tested negative for HBsAg, HCV antibody and HIV antibody at the donor level. Precautions described in CDC and FDA recommendations and OSHA blood borne pathogen rules should be followed when handling these specimens. These recommendations and rules include but are not limited to the following:
Testing Regulations
The Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) requires PT specimens to be analyzed as if they were patient specimens. To be in compliance you must not delay testing PT specimens unless your patient testing is also being delayed. Failure to participate in a testing event is unsatisfactory performance and results in a score of 0 for the testing event. Failure to return PT results or have them postmarked by the cut-off date displayed in the 2008 schedule on page 2 is unsatisfactory performance and results in a score of 0 for the testing event.
Coding Your Methods
A Reporting Form Instruction Sheet is included with each shipment. The back of this sheet lists method data on file only for analytes for which results were submitted in the most recent survey. Since this data will determine how currently reported results will be evaluated, please verify the entries in this list. If an entry is correct, do not recode it.
If entries are missing or incorrect, please amend this list by coding/recoding method data directly on your results form(s). Methods for whole blood glucose and antigen screens must be entered each time. Do not return the Instruction Sheet.
To code methods, ensure that you use current method codes by referring only to those listed in red and white reporting form, the General Instructions pages or the Method Code Addendum for the current event. Only method codes (not method descriptions) can be used to code participants' methods on the reporting forms. If no acceptable method description can be found in the method list, leave the method code blank, paper clip a package insert and/or method description to the report and we will code your method. Please write your AAB account number on the insert to allow us to match the new method with your results. If you do not report, or if you are late in reporting your results for an event, your method codes will be deleted from our database. You must recode all methods, reagents and instruments the following event or your results will be graded as “Method Code Not Reported.”
Coding a method other than the one actually being used usually jeopardizes a participant's grading, even when results are transformed to mimic those of the method coded. We strongly recommend that participants report their results without transforming them to look like results from a method other than the one actually being used. Reporting untransformed results is not in violation of CLIA '88. CLIA '88 mandates that sample processing (not result processing) conform to that routinely applied to patient specimens.
CMS SCORING INSTRUCTIONS
To have your scores sent to CMS, your State Agency or COLA, place an "X" in the YES boxes on the reporting form. These boxes must be marked each reporting event. Scores will appear on the CMS cumulative score sheet only for those analytes that are checked YES. If the boxes are checked NO, no scores will be sent to CMS and will be indicated by a “DC” on the cumulative report unless state regulations override your request.
Choose only one analyte within the following groups to report to CMS. If multiple analytes are marked, only scores from the first listed analyte will be sent to CMS.
Antigen Screen
Strep A Antigen Screen
Chlamydia Antigen Screen
GC Antigen Screen
Strep B Antigen Screen
C. Difficile Antigen Screen
Chloride/Potassium/Sodium
Basic Chemistry
Blood Gases
CK-MB
Cardiac Markers/Isoenzymes
Cardiac Markers/Isoenzymes, Plasma
Coagulation
Coaguchek PT, Comp
Prothrombin Time (PT)
Whole Blood Prothrombin Time
Glucose
Serum Glucose
Whole Blood Glucose
Hematology
Cell Identification
WBC Differential
Parasitology
Cryptosporidium
Giardia
Parasitology
HCG/Pregnancy
hCG/b-hCG (quantitative)
Serum pregnancy, (qual-Basic Ch)
Serum pregnancy, (qualitative)
Urine pregnancy (qualitative)
HIV
Anti-HIV-1 or 1/2 Screen
Anti-HIV-1 Confirmation
Anti-HIV-2 Screen
Anti-HIV-2 Confirmation
HIV-1 p24 Antigen
Oral Fluid HIV Screen
Oral Fluid HIV Western Blot
Microbiology
Bacteriology
Gardnerella Affirm
GC Culture
Throat Culture
Throat/Urine Culture
Urine Culture
Syphilis Serology
FTA-ABS
MHA-TP/TP-PA
VDRL/USR
EIA
RPR, RST, trust
Please follow all directions in filling out your reporting form completely, including the “YES” and “NO” boxes for CMS reporting. Once a report is graded, CMS does not allow for corrections due to participant’s clerical and/or omission errors.
Address Changes
Address changes must be received in writing by either fax or mail on institutional letterhead. Notice must be received 14 days prior to the next shipment date for the address to be updated. Participants will be responsible for shipping charges to resend a shipment due to a late address change.
Cancellation Policy
A cancellation notice, on institutional letterhead, must be received by fax, email or mail 21 days prior to the shipping date in order to receive a credit or refund on a future shipment. Late enrollments received within the 21 days prior to the shipment waive the cancellation policy and no credit will be issued. The registration fee is nonrefundable.